A detailed history of Argentarii, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Argentarii, LLC holds 12,732 shares of EW stock, worth $995,769. This represents 0.46% of its overall portfolio holdings.

Number of Shares
12,732
Previous 3,452 268.83%
Holding current value
$995,769
Previous $256 Million 261.11%
% of portfolio
0.46%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025

BUY
$67.95 - $76.19 $630,576 - $707,043
9,280 Added 268.83%
12,732 $923 Million
Q4 2024

Feb 07, 2025

BUY
$64.54 - $75.92 $222,792 - $262,075
3,452 New
3,452 $256 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $48.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Argentarii, LLC Portfolio

Follow Argentarii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argentarii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argentarii, LLC with notifications on news.